Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders
about
Skeletal muscle as a therapeutic target for delaying type 1 diabetic complicationsMyostatin: expanding horizonsOverexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβOocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factorsSporadic inclusion body myositis: new insights and potential therapy.Large-scale serum protein biomarker discovery in Duchenne muscular dystrophyMyostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay.Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopenia.Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy.Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia.Muscle Derived Stem Cells Stimulate Muscle Myofiber Repair and Counteract Fat Infiltration in a Diabetic Mouse Model of Critical Limb Ischemia.Living long and ageing well: is epigenomics the missing link between nature and nurture?Human sports drug testing by mass spectrometry.Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.Follistatin N terminus differentially regulates muscle size and fat in vivo.Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technologyTGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice.Quantitative measurements of GDF-8 using immunoaffinity LC-MS/MS.A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolguNutrition and Muscle in Cirrhosis.Tolloid cleavage activates latent GDF8 by priming the pro-complex for dissociation.Structure of the human myostatin precursor and determinants of growth factor latency.Alleviating exercise-induced muscular stress using neat and processed bee pollen: oxidative markers, mitochondrial enzymes, and myostatin expression in rats.Endoplasmic Reticulum Stress Induces Myostatin High Molecular Weight Aggregates and Impairs Mature Myostatin Secretion.Myostatin dysfunction is associated with reduction in overload induced hypertrophy of soleus muscle in mice.Does Activin Receptor Blockade by Bimagrumab (BYM338) Pose Detrimental Effects on Bone Healing in a Rat Fibula Osteotomy Model?Emerging roles for histone deacetylases in age-related muscle atrophy.
P2860
Q26775403-97D8C320-7758-42BE-9859-62726384825BQ26797484-AD6D077E-74DC-404A-9D13-FD8F60767FD9Q27308903-824556A1-1277-4BFC-A550-296386C64635Q28069613-CF294E93-00F9-4D4D-A60A-4A59E637232AQ34591787-760819EE-AD76-40E8-AC9F-355E6B352D00Q35740280-329DEED6-38DD-4ED4-B84B-5C43B2C08577Q35853649-22E0BA07-C3D2-44C4-B933-8D58BC97D890Q36500787-C106B0B4-4970-479D-85E9-574B33E25A2AQ37066013-2D1D74A4-AAF5-4AE0-BD83-FE4FB6EBC735Q37074556-13BAA7B3-0678-4B2A-AB12-A84F6A435359Q37646812-D9CEE112-F1F9-4C29-8651-62FD3AAA4DADQ38541612-8C5778DA-EB02-471F-A7FE-2BD3621A0166Q38554891-19AD65A5-7311-4DDB-BBB2-0AF49B16BA81Q38912441-B750D449-57C5-4126-B50E-4EFC48D0995EQ40040011-65B9F119-A814-4900-A486-EB09FEF227B6Q40640594-FB37B575-D2E0-4552-9C9A-0829F0A48764Q41682130-F9BC37ED-E04D-4E04-8B06-A07497049D12Q43095052-728119A3-6C8D-438F-850F-10232FEBEFF2Q46380539-BDFED9D9-CCD8-4B63-B33F-76A569A0A271Q46600197-08C735EB-5846-4D58-8CA1-ECC3DB4CA895Q47127942-678EC8D6-C208-4D6F-917E-7F6092886862Q47300465-AF5B9AB6-189F-4680-A7DD-32FC5E2796E8Q48224207-622982EC-E987-4016-AB14-F5146EB5A959Q48252001-1BE95DD2-0317-4FFD-BFCC-3DAC9E19A8F1Q50915617-92B96339-3318-48F9-B391-828AF319C859Q52726177-D9A90D3F-CB20-41F8-83CC-79A3D7764756Q52862926-129FDC57-7EA4-4C46-82EF-7BA5EECF7E73Q54195072-F8B8FBAB-8256-4C15-AB91-A66FAD480CA6Q54997679-2E641362-5A14-447D-9EDA-B1390E2DAE6F
P2860
Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Myostatin inhibitors as therap ...... ith cancer and other disorders
@en
type
label
Myostatin inhibitors as therap ...... ith cancer and other disorders
@en
prefLabel
Myostatin inhibitors as therap ...... ith cancer and other disorders
@en
P2860
P921
P1476
Myostatin inhibitors as therap ...... ith cancer and other disorders
@en
P2093
Boris K Lin
Rosamund C Smith
P2860
P304
P356
10.1097/SPC.0000000000000013
P5008
P577
2013-12-01T00:00:00Z